Canada markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9000+0.0620 (+7.40%)
At close: 04:00PM EDT
0.9000 0.00 (0.00%)
After hours: 07:56PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
1,446
0
0
1,022
2,757
Operating Expenses
Research Development
40,206
36,936
16,956
24,083
23,000
Selling General and Administrative
7,514
7,310
6,445
6,026
3,874
Total Operating Expenses
46,185
42,711
22,401
30,109
26,874
Operating Income or Loss
-44,739
-42,711
-22,401
-29,087
-24,117
Interest Expense
-
-
-
-
420
Total Other Income/Expenses Net
-332
763
-9
-951
1,592
Income Before Tax
-45,557
-42,193
-22,333
-29,681
-22,105
Income from Continuing Operations
-45,557
-42,193
-22,333
-29,681
-22,105
Net Income
-45,557
-42,193
-22,333
-29,681
-22,105
Net Income available to common shareholders
-48,698
-46,320
-22,333
-29,681
-23,462
Basic EPS
-
-3.85
-2.44
-3.51
-7.02
Diluted EPS
-
-3.85
-2.44
-3.51
-7.02
Basic Average Shares
-
12,292
9,169
8,458
3,147
Diluted Average Shares
-
12,292
9,169
8,458
3,147
EBITDA
-
-42,276
-22,064
-28,749
-23,834